Compare $ESLA vs $MRKR | Chartloom

Compare

$ESLA vs $MRKR

Estrella Immunopharma Inc · Marker Therapeutics Inc

ESLA

Estrella Immunopharma Inc

MRKR

Marker Therapeutics Inc

Compare $ESLA vs $MRKR

Comparing Estrella Immunopharma Inc and Marker Therapeutics Inc

ESLAEstrella Immunopharma Inc

MRKRMarker Therapeutics Inc

ESLAEstrella Immunopharma Inc

Market cap

$18M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-70.5%

52W performance

-68.5%

FCF yield

-53.2%

MRKRMarker Therapeutics Inc

Market cap

$16M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.16x

Rev growth (TTM)

-46.2%

YTD performance

-36.9%

52W performance

-10.0%

FCF yield

-60.2%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ESLA

MRKR

Detailed metrics comparison

ESLA

Estrella Immunopharma Inc

MRKR

Marker Therapeutics Inc

Market Cap

ESLA$18M

MRKR$16M

Enterprise Value

ESLA$17M

MRKR$5M

Price

ESLA$0.41

MRKR$0.97

P/E Ratio

ESLAN/A

MRKRN/A

P/S Ratio

ESLA0.00x

MRKR6.93x

EV/Sales

ESLA0.00x

MRKR2.08x

EV/EBITDA

ESLA0.00x

MRKR0.00x

P/B Ratio

ESLA141.63x

MRKR1.44x

P/FCF Ratio

ESLAN/A

MRKRN/A

EV/FCF

ESLA-1.86x

MRKR-0.50x

PEG Ratio

ESLAN/A

MRKRN/A

Forward P/E (NTM)

ESLAN/A

MRKRN/A

Forward P/S (NTM)

ESLAN/A

MRKR3.16x

Revenue (TTM)

ESLA$0

MRKR$2M

Revenue Growth (YoY)

ESLAN/A

MRKR-46.2%

Forward Rev Growth

ESLA0.0%

MRKR375.8%

Gross Margin (TTM)

ESLA0.0%

MRKR0.0%

Operating Margin (TTM)

ESLA0.0%

MRKR0.0%

EBITDA Margin (TTM)

ESLA0.0%

MRKR-284.3%

Net Margin (TTM)

ESLA0.0%

MRKR-236.6%

FCF Margin (TTM)

ESLAN/A

MRKR-417.6%

Net Income (TTM)

ESLA$-10M

MRKR$-6M

FCF (TTM)

ESLA$-9M

MRKR$-10M

EPS (TTM)

ESLA-$0.23

MRKR-$0.27

ROE (TTM)

ESLA-25911.0%

MRKR-8086.0%

ROA (TTM)

ESLA-32876.0%

MRKR-6705.0%

ROIC (TTM)

ESLA-25911.0%

MRKR-8086.0%

Cash

ESLA$147K

MRKR$11M

Debt

ESLA$0

MRKR$0

Net Cash/Debt

ESLA$147K

MRKR$11M

Current Ratio (TTM)

ESLA0.20x

MRKR6.03x

Quick Ratio (TTM)

ESLA0.02x

MRKR5.60x

Debt/Equity (TTM)

ESLA0.00x

MRKR0.00x

Debt/Assets (TTM)

ESLA0.0%

MRKR0.0%

Interest Coverage (TTM)

ESLAN/A

MRKRN/A

Net Debt/EBITDA (TTM)

ESLA0.00x

MRKR0.00x

Beta

ESLA0.98

MRKR1.59

52W Performance

ESLA-68.5%

MRKR-10.0%

YTD Performance

ESLA-70.5%

MRKR-36.9%

% from 52W High

ESLA-87.0%

MRKR-60.5%

% from 52W Low

ESLA33.0%

MRKR15.7%

Asset Turnover (TTM)

ESLA0.00x

MRKR0.20x

FCF Yield (TTM)

ESLA-53.2%

MRKR-60.2%

Earnings Yield (TTM)

ESLA-56.8%

MRKR-34.1%

Dividend Yield (TTM)

ESLAN/A

MRKRN/A

Rule of 40

ESLA0.0

MRKR-463.8

EV/GP/RG

ESLAN/A

MRKRN/A

Ticker research

View ESLA research View MRKR research

Metric	ESLA Estrella Immunopharma Inc	MRKR Marker Therapeutics Inc
Market & Valuation
Market Cap	$18M	$16M
Enterprise Value	$17M	$5M
Price	$0.41	$0.97
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	6.93x
EV/Sales	0.00x	2.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	141.63x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.86x	-0.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.16x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-46.2%
Forward Rev Growth	0.0%	375.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-284.3%
Net Margin (TTM)	0.0%	-236.6%
FCF Margin (TTM)	N/A	-417.6%
Net Income (TTM)	$-10M	$-6M
FCF (TTM)	$-9M	$-10M
EPS (TTM)	-$0.23	-$0.27
ROE (TTM)	-25911.0%	-8086.0%
ROA (TTM)	-32876.0%	-6705.0%
ROIC (TTM)	-25911.0%	-8086.0%
Financial Health
Cash	$147K	$11M
Debt	$0	$0
Net Cash/Debt	$147K	$11M
Current Ratio (TTM)	0.20x	6.03x
Quick Ratio (TTM)	0.02x	5.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.98	1.59
52W Performance	-68.5%	-10.0%
YTD Performance	-70.5%	-36.9%
% from 52W High	-87.0%	-60.5%
% from 52W Low	33.0%	15.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.20x
FCF Yield (TTM)	-53.2%	-60.2%
Earnings Yield (TTM)	-56.8%	-34.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-463.8
EV/GP/RG	N/A	N/A
Ticker research	View ESLA research	View MRKR research

Valuation

P/S Ratio

ESLA

0.00x

MRKR

6.93x

EV/FCF

ESLA

-1.86x

MRKR

-0.50x

Growth & revenue

Revenue Growth TTM

MRKR

-46.2%

Forward Revenue Growth

MRKR

375.8%

ESLA

0.0%

Profitability & performance

Gross Margin

ESLA

0.0%

MRKR

0.0%

ROE

MRKR

-8086.0%

ESLA

-25911.0%

FCF Yield %

ESLA

-53.2%

MRKR

-60.2%

52-Week Performance

MRKR

-10.0%

ESLA

-68.5%

Detailed metrics comparison

ESLA

Estrella Immunopharma Inc

MRKR

Marker Therapeutics Inc

Market Cap

ESLA$18M

MRKR$16M

Enterprise Value

ESLA$17M

MRKR$5M

Price

ESLA$0.41

MRKR$0.97

P/E Ratio

ESLAN/A

MRKRN/A

P/S Ratio

ESLA0.00x

MRKR6.93x

EV/Sales

ESLA0.00x

MRKR2.08x

EV/EBITDA

ESLA0.00x

MRKR0.00x

P/B Ratio

ESLA141.63x

MRKR1.44x

P/FCF Ratio

ESLAN/A

MRKRN/A

EV/FCF

ESLA-1.86x

MRKR-0.50x

PEG Ratio

ESLAN/A

MRKRN/A

Forward P/E (NTM)

ESLAN/A

MRKRN/A

Forward P/S (NTM)

ESLAN/A

MRKR3.16x

Revenue (TTM)

ESLA$0

MRKR$2M

Revenue Growth (YoY)

ESLAN/A

MRKR-46.2%

Forward Rev Growth

ESLA0.0%

MRKR375.8%

Gross Margin (TTM)

ESLA0.0%

MRKR0.0%

Operating Margin (TTM)

ESLA0.0%

MRKR0.0%

EBITDA Margin (TTM)

ESLA0.0%

MRKR-284.3%

Net Margin (TTM)

ESLA0.0%

MRKR-236.6%

FCF Margin (TTM)

ESLAN/A

MRKR-417.6%

Net Income (TTM)

ESLA$-10M

MRKR$-6M

FCF (TTM)

ESLA$-9M

MRKR$-10M

EPS (TTM)

ESLA-$0.23

MRKR-$0.27

ROE (TTM)

ESLA-25911.0%

MRKR-8086.0%

ROA (TTM)

ESLA-32876.0%

MRKR-6705.0%

ROIC (TTM)

ESLA-25911.0%

MRKR-8086.0%

Cash

ESLA$147K

MRKR$11M

Debt

ESLA$0

MRKR$0

Net Cash/Debt

ESLA$147K

MRKR$11M

Current Ratio (TTM)

ESLA0.20x

MRKR6.03x

Quick Ratio (TTM)

ESLA0.02x

MRKR5.60x

Debt/Equity (TTM)

ESLA0.00x

MRKR0.00x

Debt/Assets (TTM)

ESLA0.0%

MRKR0.0%

Interest Coverage (TTM)

ESLAN/A

MRKRN/A

Net Debt/EBITDA (TTM)

ESLA0.00x

MRKR0.00x

Beta

ESLA0.98

MRKR1.59

52W Performance

ESLA-68.5%

MRKR-10.0%

YTD Performance

ESLA-70.5%

MRKR-36.9%

% from 52W High

ESLA-87.0%

MRKR-60.5%

% from 52W Low

ESLA33.0%

MRKR15.7%

Asset Turnover (TTM)

ESLA0.00x

MRKR0.20x

FCF Yield (TTM)

ESLA-53.2%

MRKR-60.2%

Earnings Yield (TTM)

ESLA-56.8%

MRKR-34.1%

Dividend Yield (TTM)

ESLAN/A

MRKRN/A

Rule of 40

ESLA0.0

MRKR-463.8

EV/GP/RG

ESLAN/A

MRKRN/A

Ticker research

View ESLA research View MRKR research

Metric	ESLA Estrella Immunopharma Inc	MRKR Marker Therapeutics Inc
Market & Valuation
Market Cap	$18M	$16M
Enterprise Value	$17M	$5M
Price	$0.41	$0.97
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	6.93x
EV/Sales	0.00x	2.08x
EV/EBITDA	0.00x	0.00x
P/B Ratio	141.63x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-1.86x	-0.50x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	3.16x
Revenue & Growth
Revenue (TTM)	$0	$2M
Revenue Growth (YoY)	N/A	-46.2%
Forward Rev Growth	0.0%	375.8%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-284.3%
Net Margin (TTM)	0.0%	-236.6%
FCF Margin (TTM)	N/A	-417.6%
Net Income (TTM)	$-10M	$-6M
FCF (TTM)	$-9M	$-10M
EPS (TTM)	-$0.23	-$0.27
ROE (TTM)	-25911.0%	-8086.0%
ROA (TTM)	-32876.0%	-6705.0%
ROIC (TTM)	-25911.0%	-8086.0%
Financial Health
Cash	$147K	$11M
Debt	$0	$0
Net Cash/Debt	$147K	$11M
Current Ratio (TTM)	0.20x	6.03x
Quick Ratio (TTM)	0.02x	5.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.98	1.59
52W Performance	-68.5%	-10.0%
YTD Performance	-70.5%	-36.9%
% from 52W High	-87.0%	-60.5%
% from 52W Low	33.0%	15.7%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.20x
FCF Yield (TTM)	-53.2%	-60.2%
Earnings Yield (TTM)	-56.8%	-34.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-463.8
EV/GP/RG	N/A	N/A
Ticker research	View ESLA research	View MRKR research